Data / Form D filings / Celmatix Inc.
Celmatix Inc.: Form D filings
Celmatix Inc., a biotechnology company in New York, NY, filed 6 Form D notices with the SEC between 2011 and 2016. The latest, on April 1, 2016, reports $4.8 million sold of a $4.8 million offering to 1 investor.
Find out what Celmatix Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 14 WALL STREET, Suite 16D, New York, NY, 10005
- Phone
- (646) 568-3234
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1514000
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2016 | New notice | $4,799,999 | $4,799,999 | $0 | 1 | Mar 18, 2016 | sec.gov |
| Sep 15, 2015 | New notice | $5,151,643 | $3,757,754 | $1,393,889 | 5 | Aug 31, 2015 | sec.gov |
| Jul 17, 2015 | New notice | $5,510,000 | $5,510,000 | $0 | 6 | Dec 3, 2014 | sec.gov |
| Feb 21, 2013 | New notice | $6,012,491 | $4,012,850 | $1,999,641 | 13 | Feb 12, 2013 | sec.gov |
| Mar 2, 2012 | New notice | $1,499,997 | $1,499,997 | $0 | 10 | Feb 21, 2012 | sec.gov |
| Feb 25, 2011 | New notice | $806,129 | $806,129 | $0 | 10 | Feb 16, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Piraye Yurttas Beim | Executive Officer, Director | |
| Laura Yurttas Bandak | Director | |
| Steven J. Winick | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Mar 28, 2016 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Celmatix Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.